Chemotherapy Devices Market Generated Opportunities, Future Scope 2021-2028 | Advanced Chemotherapy Technologies, Baxter International, Becton

The Global Chemotherapy Devices Market, accounted for US$ 10.9 billion in 2017, and is expected to witness a 7.7% CAGR over the forecast period (2018 - 2026).

Technological advancements within cancer treatments including chemotherapy along with rising cancer care investments are decreasing the number of deaths caused by cancer worldwide. As per the 2016 study by Cancer Journal for Clinicians, the amount of cancer survivors grows continuously in the U.S., owing to rising number of novel cancer diagnoses causing from an aging population.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2231

According to the same report, on January 1, 2016 around 15.5 Mn people in the U.S. with a cancer history were alive and the number is expected to reach at 20.3 Mn till January 1, 2026. Chemotherapy most often is administrated through a vein (intravenously) with the help of devices including ports and catheter. Long-term CAVD (central venous access devices) are crucial for managing cancer patients, since they minimize discomfort of frequent cannulation and venipuncture. A catheter decreases the frequency of inserting a needle in patient’s vein. As per the 2017 report from the World Health Organization, in majority upper and middle income nations, the dosage of chemotherapy for certain treatments along with for metastatic disease patients is done with the help of peripherally inserted central catheters (PICC) or implantable central venous catheters.

Manufacturers within the market are focused on the devices’ technological advancements. For instance, Advanced Chemotherapy Technologies, in May 2018, announced an implant’s development, around a large coin’s size for chemo agents’ direct delivery in the pancreas. RenovoRx, in 2017, received the approval from the Food and Drug Administration approval RenovoCath – a dual-balloon infusion catheter for including the chemotherapeutics delivery.

Global Chemotherapy Devices Market: Key Takeaways

The global chemotherapy devices market is expected to proliferate at a 7.7% CAGR over the forecast period (2018–2026), due to increasing prevalence of cancer incidence combined with increasing alcohol and tobacco consumption, and rising base of geriatric population.

On the basis of product, the segment of pumps is expected to produce significant revenue share in 2018, owing to high cost, in comparison with other products.

Major players functioning in the global chemotherapy devices market are Advanced Chemotherapy Technologies, Becton, Baxter International, Dickinson, Fresenius Kabi, B. Braun, Halyard Health, Moog Inc., ICU Medical, Micrel Medical, Terumo Corporation, Smiths Group, Zyno Medical, and Terumo Corporation.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2231

View More Reports

Chemiluminescence Immunoassay Market - https://www.coherentmarketinsights.com/market-insight/chemiluminescence-immunoassay-market-4656

Chronic Aspergillosis Treatment Market - https://www.coherentmarketinsights.com/press-release/chronic-aspergillosis-treatment-market-3861

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.